advanced-ovarian-cancer

Documents about advanced-ovarian-cancer

• Role of Surgery in Advanced Ovarian Cancer#1421682ClinicalTrials.gov
• SC0191 Plus Chemotherapy in Advanced Ovarian Canceradvanced Ovarian Cancer#1151438ClinicalTrials.gov
• Advanced Ovarian Cancer and Sexuality Phase 1#853205ClinicalTrials.gov
• Plasmodium Immunotherapy for Advanced Ovarian Cancer#633729ClinicalTrials.gov
• Reduction Of Cycles of neOadjuvant Chemotherapy for Advanced Epithelial Ovarian, Fallopian and Primary Peritoneal Cancer#885596ClinicalTrials.gov
• To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal Cancers#857120ClinicalTrials.gov
• A Phase I/II Study of CP-4055 in Patients With Platinum Resistant Ovarian Cancer#1162281ClinicalTrials.gov
• SBRT-LDRT-Cadonilimab for Advanced Gastric, Colorectal and Ovarian Cancers With Peritoneal Metastases#1440287ClinicalTrials.gov
• Overcoming Chemoresistance in Advanced Ovarian Cancer Via Targeting Hypoxia#1128019ClinicalTrials.gov
• Primary Debulking Surgery Including Bowel Resection in Advanced Stage Ovarian Cancer Using Caiman® Technology#1308818ClinicalTrials.gov
• AZD0530 Phase II Study in Patients With Advanced Ovarian Cancer#1058333ClinicalTrials.gov
• PAZOFOS: Phase Ib and Phase II Trial of Pazopanib +/- Fosbretabulin in Advanced Recurrent Ovarian Cancer#1184005ClinicalTrials.gov
• Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)#1430372ClinicalTrials.gov
• Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer#1322496ClinicalTrials.gov
• AK104 Combined With Chemotherapy as Neoadjuvant Treatment for Advanced Ovarian Cancer#651247ClinicalTrials.gov
• ULTRA-LAP Trial: Laparoscopic Debulking Surgery (LDS) in Advanced Ovarian Cancer#1162866ClinicalTrials.gov
• A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer#968631ClinicalTrials.gov
• A Study of MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor Alpha#829321ClinicalTrials.gov
• Retarded Surgery Following Neoadjuvant Chemotherapy in Advanced Ovarian Cancer#825575ClinicalTrials.gov
• ZD4054 (Zibotentan) or Placebo Plus Chemotherapy in Patients With Advanced Ovarian Cancer#1283151ClinicalTrials.gov
• Hyperthermic Intraperitoneal Chemotherapy With Paclitaxel in Advanced Ovarian Cancer#878360ClinicalTrials.gov
• Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.#1376545ClinicalTrials.gov
• Study of SC10914 in Patients With gBRCA1/2 Mutation Advanced Ovarian Cancer#875579ClinicalTrials.gov
• Dose-dense Chemotherapy Versus Intraperitoneal Chemotherapy as First-line Chemotherapy in Advanced Ovarian Cancer#882987ClinicalTrials.gov
• Trial on Radical Upfront Surgery in Advanced Ovarian Cancer#886045ClinicalTrials.gov
• The Preoperative Predictors of Optimal Cytoreductive Surgery in Women With Advanced Ovarian Cancer#1408909ClinicalTrials.gov
• Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer#871992ClinicalTrials.gov
• The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian Cancer#123449ClinicalTrials.gov
• Predicting Outcome of Cytoreduction in Advanced Ovarian Cancer#902938ClinicalTrials.gov
• Characterizing the Cross-sectional Approach to Investigate the Prevalence of Tissue BRCA1/2 Mutations in Newly Diagnosed Advanced Ovarian Cancer Patients#1431547ClinicalTrials.gov
• Dynamic Monitoring of ctDNA Predicts Recurrence of Advanced Ovarian Cancer After Primary Treatments#1397831ClinicalTrials.gov
• Impact of Gated PET/CT in the Diagnosis of Advanced Ovarian Cancer#871376ClinicalTrials.gov
• HS-10502 Combination Treatment in Patients With Advanced Solid Tumors#1047783ClinicalTrials.gov
• PankoMab-GEX™ Versus Placebo as Maintenance Therapy in Advanced Ovarian Cancer#1164085ClinicalTrials.gov
• An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer#1163916ClinicalTrials.gov
• Sequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian Cancer#915109ClinicalTrials.gov
• A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies.#864134ClinicalTrials.gov
• Short-course HIPEC in Advanced Epithelial Ovarian Cancer#865554ClinicalTrials.gov
• Neoadjuvant RC48 Plus Carboplatin for HER2-expressing Advanced Ovarian Cancer#889701ClinicalTrials.gov
• Minimally Invasive Interval Debulking Surgery in Advanced Ovarian Cancer#1363291ClinicalTrials.gov
• Effects of a Probiotic Intervention on the Gut and Vaginal Microbiome in Patients With Advanced or Recurrent Ovarian Cancer Undergoing Treatment With Platinum Chemotherapy#845052ClinicalTrials.gov
• Itraconazole in Advanced Ovarian Cancer#1153372ClinicalTrials.gov
• Study to Compare the Efficacy and Safety of Olaparib When Given in Combination With Carboplatin and Paclitaxel, Compared With Carboplatin and Paclitaxel in Patients With Advanced Ovarian Cancer#1139627ClinicalTrials.gov
• Application of Cardiophrenic Lymphadenectomy in Advanced Ovarian Cancer: A Single-Center Prospective Exploratory Study#880615ClinicalTrials.gov
• Open Trial of Bendamustine Hydrochloride in Women With Advanced Ovarian Cancer#1072334ClinicalTrials.gov
• Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer#1139828ClinicalTrials.gov
• Safety, Tolerability and Pharmacokinetics of MORAb-003 in Subjects With Advanced Ovarian Cancer#1163509ClinicalTrials.gov
• Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer#1259280ClinicalTrials.gov
• Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer#1124820ClinicalTrials.gov
• A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies#1088153ClinicalTrials.gov